Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.
Hum Vaccin Immunother
; 19(1): 2194190, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: covidwho-20234553
ABSTRACT
WHO-recommended vaccines substantially prevent and control vaccine-preventable diseases (VPDs), but their inclusion differs among countries and regions. We reviewed the application for WHO-recommended vaccines in China and described the concerns and obstacles in driving the inclusion of more vaccines into China's NIP, including immunization strategies, financial barriers, vaccination services, and behavioral and social supply-side and demand-side factors. China has made significant efforts, however, they may not be sufficient until the inclusion of more WHO-recommended vaccines in the National Immunization Program (NIP), ensuring that the vaccination encompasses the whole life course of individuals, establishment of more trustworthy vaccination finance and procurement, increasing vaccine development, optimizing vaccine demand forecasts, improving the accessibility and equity of vaccination services, capturing the key points of behavioral and social drivers of vaccination on the demand side, and establishing holistic prevention and control from a public health perspective.
Palavras-chave
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
MEDLINE
Assunto principal:
Vacinas
/
Vacinação
Tipo de estudo:
Estudo prognóstico
Tópicos:
Vacinas
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Hum Vaccin Immunother
Ano de publicação:
2023
Tipo de documento:
Artigo
País de afiliação:
21645515.2023.2194190
Similares
MEDLINE
...
LILACS
LIS